Products found to contain undeclared medicines
|
| |
| The United States: Bella all Natural Issues Voluntary Nationwide Recall of Diet Capsules Labeled as Bella, Due to Presence of Sibutramine |
| |
The US Food and Drug Administration (FDA) has announced that Bella All Natural is voluntarily recalling its Diet Capsules labeled as Bella, Lot Number MFD:10.15.2017 EXP: 10.14.2019, to the consumer level.
This recall has been initiated due to presence of sibutramine. Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010 due to safety concerns. N-Desmethyl sibutramine is an active metabolite of sibutramine. Sibutramine and its active metabolites substantially increase blood pressure and/or pulse rate in some patients and may present significant health risks including heart attack, arrhythmia, and stroke. The company has not received any reports of adverse events or injuries. The product is used as a diet pill and is packaged in a plastic bottle, with 30 pills, and with the Lot Number MFD: 10.15.2017 EXP: 10.14.2019. Bella was distributed in California via internet and retail.
Bella All Natural is notifying its distributors and customers by Customer Notification/Recall Communication and is arranging for return of product of all recalled products. Consumers that have Bella Diet Capsules which is being recalled should stop using immediately and return to place of purchase.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/Recalls/ucm598087.htm
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Saturday, Feb 24, 2018
Issued at HKT 12:00
|
| |
